All Stories

  1. Methylation of FBN1, SPG20, ITF2, RUNX3, SNCA, MLH1, and SEPT9 genes in circulating cell-free DNA as biomarkers of colorectal cancer

    Article • Cancer Biomarkers, May 2022, IOS Press

    Ladan Teimoori-Toolabi

  2. Multi-targeting of K-Ras domains and mutations by peptide and small molecule inhibitors

    Article • PLoS Computational Biology, April 2022, PLOS

    Ladan Teimoori-Toolabi

  3. Improved microsatellite instability detection in colorectal cancer patients by a combination of fourteen markers especially DNMT3a, DCD, and MT1X

    Article • Cancer Biomarkers, July 2021, IOS Press

    Ladan Teimoori-Toolabi

  4. Hypermethylated RASSF1 and SLC5A8 promoters alongside BRAF V600E mutation as biomarkers for papillary thyroid carcinoma

    Article • Journal of Cellular Physiology, February 2020, Wiley

    Ladan Teimoori-Toolabi

  5. Identification of candidate genes and miRNAs for sensitizing resistant colorectal cancer cells to oxaliplatin and irinotecan

    Article • Cancer Chemotherapy and Pharmacology, November 2019, Springer Science + Business Media

    Ladan Teimoori-Toolabi

  6. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications

    Article • Current Drug Targets, May 2019, Bentham Science Publishers

    Ladan Teimoori-Toolabi

  7. Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p

    Article • Biomedicine & Pharmacotherapy, December 2018, Elsevier

    Ladan Teimoori-Toolabi

  8. Aberrant expression of miR-141 and nuclear receptor small heterodimer partner in clinical samples of prostate cancer

    Article • Cancer Biomarkers, May 2018, IOS Press

    Ladan Teimoori-Toolabi

  9. Altered DNA methyltransferases promoter methylation and mRNA expression are associated with tamoxifen response in breast tumors

    Article • Journal of Cellular Physiology, March 2018, Wiley

    Ladan Teimoori-Toolabi

  10. Myc Decoy Oligodeoxynucleotide Inhibits Growth and Modulates Differentiation of Mouse Embryonic Stem Cells as a Model of Cancer Stem Cells

    Article • Anti-Cancer Agents in Medicinal Chemistry, January 2018, Bentham Science Publishers

    behrooz johari, Ladan Teimoori-Toolabi

  11. HMW1555-914, HMW2553-916, and Hia585-705 as Subunit Vaccine Candidates of Nontypeable Haemophilus influenzae Induce Specific Antibody Responses with Bactericidal Activity in Balb/c

    Article • Jundishapur Journal of Microbiology, October 2017, Kowsar Medical Institute

    Ladan Teimoori-Toolabi

  12. Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer

    Article • PLoS ONE, September 2017, PLOS

    Ladan Teimoori-Toolabi

  13. MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells

    Article • Cancer Chemotherapy and Pharmacology, September 2017, Springer Science + Business Media

    Ladan Teimoori-Toolabi

  14. MiR-377 reverses cancerous phenotypes of pancreatic cells via suppressing DNMT1 and demethylating tumor suppressor genes

    Article • Epigenomics, August 2017, Future Medicine

    Ladan Teimoori-Toolabi

  15. Construction of Various γ34.5 Deleted Fluorescent-Expressing Oncolytic Herpes Simplex Virus Type 1 (oHSV-1) for Generation and Isolation of HSV-Based Vectors

    Article • Iranian Biomedical Journal, July 2017, CASRP: Center of Advanced Scientific Research and Publications

    Ladan Teimoori-Toolabi

  16. Pattern of LRP6 expression

    Article • Cancer Biomarkers, May 2017, IOS Press

    Ladan Teimoori-Toolabi

  17. Computationally Design of Inhibitory Peptides Against Wnt Signaling Pathway: In Silico Insight on Complex of DKK1 and LRP6

    Article • International Journal of Peptide Research and Therapeutics, April 2017, Springer Science + Business Media

    Ladan Teimoori-Toolabi

  18. Autophagy induction reduces telomerase activity in HeLa cells

    Article • Mechanisms of Ageing and Development, April 2017, Elsevier

    Ladan Teimoori-Toolabi

  19. Evaluation of an Albumin-Binding Domain Protein Fused to Recombinant Human IL-2 and Its Effects on the Bioactivity and Serum Half-Life of the Cytokine

    Article • Iranian Biomedical Journal, March 2017, CASRP: Center of Advanced Scientific Research and Publications

    Ladan Teimoori-Toolabi

  20. Molecular alterations contributing to pancreatic cancer chemoresistance

    Article • Pancreatology, March 2017, Elsevier

    Ladan Teimoori-Toolabi

  21. Rational design of DKK3 structure-based small peptides as antagonists of Wnt signaling pathway and in silico evaluation of their efficiency

    Article • PLoS ONE, February 2017, PLOS

    Ladan Teimoori-Toolabi

  22. Aberrant methylated EDNRB can act as a potential diagnostic biomarker in sporadic colorectal cancer while KISS1 is controversial

    Article • Bioengineered, January 2017, Taylor & Francis

    Ladan Teimoori-Toolabi

  23. Abstract A19: Silencing LEF1 decreases the resistance of colorectal cancer cell lines to 5-FU as common chemotherapeutic drug

    Article • January 2017, American Association for Cancer Research (AACR)

    Ladan Teimoori-Toolabi

  24. Detection of aberrant methylated SEPT9 and NTRK3 genes in sporadic colorectal cancer patients as a potential diagnostic biomarker

    Article • Oncology Letters, October 2016, Spandidos Publications

    Ladan Teimoori-Toolabi

  25. MiR-339 and especially miR-766 reactivate the expression of tumor suppressor genes in colorectal cancer cell lines through DNA methyltransferase 3B gene inhibition

    Article • Cancer Biology & Therapy, September 2016, Taylor & Francis

    Ladan Teimoori-Toolabi

  26. Corrigendum to “Inducible expression of indoleamine 2,3-dioxygenase attenuates acute rejection of tissue-engineered lung allografts in rats” [Gene 576/1P3 (2015) 412–420]

    Article • Gene, May 2016, Elsevier

    Ladan Teimoori-Toolabi

  27. Precise and efficient siRNA design: a key point in competent gene silencing

    Article • Cancer Gene Therapy, March 2016, Springer Science + Business Media

    Ladan Teimoori-Toolabi

  28. Boule gene expression underpins the meiotic arrest in spermatogenesis in male rainbow trout ( Oncorhynchus mykiss ) exposed to DEHP and butachlor

    Article • General and Comparative Endocrinology, January 2016, Elsevier

    Ladan Teimoori-Toolabi

  29. Inducible expression of indoleamine 2,3-dioxygenase attenuates acute rejection of tissue-engineered lung allografts in rats

    Article • Gene, January 2016, Elsevier

    Ladan Teimoori-Toolabi

  30. Abstract B2-44: Structure-based design of inhibitory peptides for LRP6

    Article • November 2015, American Association for Cancer Research (AACR)

    Ladan Teimoori-Toolabi

  31. cyp51Agene silencing using RNA interference in azole-resistantAspergillus fumigatus

    Article • Mycoses, October 2015, Wiley

    Dr Hamid Badali, Ladan Teimoori-Toolabi

  32. P-214 Pattern of Dipkoff-2 gene expression in tumoral tissues of colorectal cancer and two tumor tissues of colorectal cancer and three cell lines (HUVEC, SW480 and HCT116)

    Article • Annals of Oncology, June 2015, Elsevier

    Ladan Teimoori-Toolabi

  33. Silencing the wild-type and mutant K-ras increases the resistance to 5-flurouracil in HCT-116 as a colorectal cancer cell line

    Article • Anti-Cancer Drugs, February 2015, Wolters Kluwer Health

    Ladan Teimoori-Toolabi

  34. Abstract 3769: K-ras Silencing has diverse effect on the response of cells to chemotherapeutic drugs

    Article • September 2014, American Association for Cancer Research (AACR)

    Ladan Teimoori-Toolabi

  35. TCF4 silencing sensitizes the colon cancer cell line to oxaliplatin as a common chemotherapeutic drug

    Article • Anti-Cancer Drugs, September 2014, Wolters Kluwer Health

    Ladan Teimoori-Toolabi

  36. Application of the 3′-noncoding region of poliovirus RNA for cell-based regulation of mRNA stability: Implication for biotechnological applications

    Article • Biotechnology and Applied Biochemistry, April 2014, Wiley

    Ladan Teimoori-Toolabi

  37. MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines

    Article • Cancer Biology & Therapy, January 2014, Taylor & Francis

    Ladan Teimoori-Toolabi

  38. RNA-Mediated Gene Silencing in Candida albicans: Inhibition of Hyphae Formation by Use of RNAi Technology

    Article • Mycopathologia, April 2012, Springer Science + Business Media

    Ladan Teimoori-Toolabi

  39. Abstract 1517: Wnt signaling pathway seems a better target than k-ras pathway for colon cancer specific suicide gene therapy

    Article • April 2010, American Association for Cancer Research (AACR)

    Ladan Teimoori-Toolabi

  40. Selective Suicide Gene Therapy of Colon Cancer Exploiting the Urokinase Plasminogen Activator Receptor Promoter

    Article • BioDrugs, April 2010, Springer Science + Business Media

    Ladan Teimoori-Toolabi

  41. Selective Suicide Gene Therapy of Colon Cancer Cell Lines Exploiting Fibroblast Growth Factor 18 Promoter

    Article • Cancer Biotherapy & Radiopharmaceuticals, February 2010, Mary Ann Liebert Inc

    Ladan Teimoori-Toolabi

  42. Apolipoprotein E Genotype and Age at Menopause

    Article • Annals of the New York Academy of Sciences, June 2004, Wiley

    Ladan Teimoori-Toolabi